[Beta-adrenergic agents in asthma].
作者信息
Morales A M, Osuna L A, Javier R C, Suárez F N, Aldana I O
出版信息
Rev Alerg Mex. 1996 Jan-Feb;43(1):2-4.
PMID:8901032
Abstract
摘要
相似文献
1
[Beta-adrenergic agents in asthma].[哮喘中的β-肾上腺素能药物]
Rev Alerg Mex. 1996 Jan-Feb;43(1):2-4.
2
Evaluation of combination long-acting beta-2 agonists and inhaled glucocorticosteroids for treatment of asthma.长效β2受体激动剂与吸入性糖皮质激素联合治疗哮喘的评估。
Expert Opin Drug Metab Toxicol. 2009 Aug;5(8):933-40. doi: 10.1517/17425250903127226.
3
Pharmacological management of asthma.哮喘的药物治疗
Aust Fam Physician. 1998 Jan-Feb;27(1-2):64-8, 70.
4
[Update on beta-adrenergic agonists and corticosteroid aerosols].[β-肾上腺素能激动剂和皮质类固醇气雾剂的最新进展]
Rev Alerg Mex. 1993 Nov-Dec;40(6):i-iv.
5
Partial beta 2-agonists and their impartial assessment.部分β2激动剂及其客观评估。
Chest. 1996 Nov;110(5):1131-2. doi: 10.1378/chest.110.5.1131.
6
Changes in recommended treatments for mild and moderate asthma.轻度和中度哮喘推荐治疗方法的变化。
J Fam Pract. 2004 Sep;53(9):692-700.
7
Management of chronic asthma.慢性哮喘的管理
Evid Rep Technol Assess (Summ). 2001 Sep(44):1-10.
8
Stopping long-acting beta-2 agonists.停用长效β2受体激动剂。
Med Lett Drugs Ther. 2010 Mar 22;52(1334):21.
9
Asthma.哮喘
Clin Evid. 2002 Dec(8):1506-29.
10
Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.吸入沙美特罗和氟替卡松：一项比较哮喘单一疗法与联合疗法的研究。
Ann Allergy Asthma Immunol. 1999 Mar;82(3):257-65. doi: 10.1016/S1081-1206(10)62606-3.
Zotero 插件